Corporate ActionOct 1, 2026, 11:46 AM
AstraZeneca PLC Admits 9,828 Ordinary Shares to Trading
AI Summary
AstraZeneca PLC has announced the admission of 9,828 ordinary shares to trading on the Main Market of the London Stock Exchange. These shares were issued under the company's employee share schemes between September 1 and September 30, 2026, and were admitted under a pre-existing block admission. The total number of ordinary shares in issue now stands at 1,551,053,289, and the new shares are fully fungible with existing ones.
Key Highlights
- AstraZeneca PLC admitted 9,828 ordinary shares of $0.25 each to trading on the London Stock Exchange.
- These shares were issued between September 1, 2026, and September 30, 2026.
- The admission was made under a block admission dated January 29, 2021.
- The total number of ordinary shares outstanding following this admission is 1,551,053,289.
- The newly admitted shares are fully fungible with existing ordinary shares.
Price Impact
More from AZN